当前位置: X-MOL 学术Lancet › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
First dose of misoprostol administration at home or in hospital for medical abortion between 12–22 gestational weeks in Sweden (PRIMA): a multicentre, open-label, randomised controlled trial
The Lancet ( IF 98.4 ) Pub Date : 2024-08-29 , DOI: 10.1016/s0140-6736(24)01079-1
Johanna Rydelius 1 , Helena Hognert 1 , Helena Kopp-Kallner 2 , Karin Brandell 3 , Joanna Romell 4 , Karin Zetterström 5 , Pia Teleman 6 , Kristina Gemzell-Danielsson 3
Affiliation  

Medical abortion after 12 gestational weeks often requires a stay in hospital. We hypothesised that administering the first misoprostol dose at home could increase day-care procedures as compared with overnight care procedures, shorten inpatient stays, and improve patient satisfaction.

中文翻译:


瑞典 12-22 孕周药物流产在家中或医院接受米索前列醇第一剂给药 (PRIMA):一项多中心、开放标签、随机对照试验



妊娠 12 周后药物流产通常需要住院治疗。我们假设与过夜护理程序相比,在家中服用第一剂米索前列醇可以增加日间护理程序,缩短住院时间并提高患者满意度。
更新日期:2024-08-29
down
wechat
bug